and rates of CIN grade 3 and AIS, defined as CIN3+, decreased by 80%, said Julia W. Gargano, PhD, of the CDC's National Center for Immunization and Respiratory Diseases, and colleagues.

Among women aged 20 to 24 years who were screened for cervical cancer, rates decreased by 79, 80 percent for CIN2+, CIN3+.